Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
acer negundo pollen extract
- Development stage
- Unknown
- Lead developer
- ALK Abelló
- Modality
- Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Epicutaneous, Intradermal, Subcutaneous, Sublingual, Intranasal
01
Overview
Acer negundo pollen extract is derived from the pollen of the box elder tree (Acer negundo), a species of maple native to North America. It is a well-known aeroallergen that triggers seasonal allergic rhinitis, conjunctivitis, and asthma in sensitized individuals. The extract is used for both diagnostic and therapeutic purposes. For diagnosis, it is used in skin prick tests and specific IgE blood tests (allergen code T1) to confirm sensitivity. As a therapeutic agent, it is administered via allergen immunotherapy, either as subcutaneous injections (allergy shots) or sublingual drops, to induce immune tolerance and reduce allergy symptoms upon natural exposure. Various manufacturers supply non-standardized allergenic extracts containing Acer negundo pollen for this purpose.
- Other names
- Box elder pollen extractBoxelder maple pollen extractManitoba maple pollen extractAcer negundo pollen
02
Targets
IgE (Immunoglobulin E)
Beyond the preview
Go deeper on acer negundo pollen extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on acer negundo pollen extract.